Your trusted destination for CME, CPD & Medical Education across the Middle East.
The Qatar Pediatric Endocrine and Diabetes Conference – QPEDC 2026 is a two-day, in-person multidisciplinary conference organized by Sidra Medicine, taking place on 27–28 November 2026 in Qatar. The conference focuses on advances in pediatric diabetes, obesity, growth and puberty disorders, endocrine diseases, diabetes technology, and emerging precision-medicine approaches.
QPEDC 2026 brings together pediatricians, endocrinologists, diabetologists, nurses, dietitians, researchers, and other healthcare professionals involved in the care of children and adolescents with endocrine conditions. The scientific programme covers childhood diabetes management, growth and puberty disorders, childhood obesity, thyroid and endocrine emergencies, and the future of type 1 diabetes. Sessions will explore topics such as type 2 diabetes in youth, continuous glucose monitoring, insulin pump therapy, short stature, growth hormone treatment, novel obesity therapies, and endocrine emergencies. The conference also examines emerging approaches to type 1 diabetes, including screening and prevention, immune-modulating therapies, islet transplantation, and stem-cell-based treatments. Interactive workshops, expert-led lectures, and case-based discussions provide opportunities to apply current evidence and clinical approaches to pediatric endocrine care. The event also emphasizes multidisciplinary collaboration, precision medicine, digital health, diabetes technology, and research and quality improvement
Initial approach to childhood diabetes and understanding its epidemiology.
Addressing the emerging global challenge of Type 2 diabetes in younger populations.
Practical applications of continuous glucose monitoring and insulin pump therapy.
Clinical approach, causes, and referral guidelines for children with short stature.
Understanding normal puberty, as well as precocious and delayed puberty.
Advances in growth hormone therapy, including the rise of long-acting formulations.
Definition, causes, and clinical approach to managing childhood obesity.
Exploring emerging therapies and novel treatments for monogenic obesity.
Implementing healthy lifestyle choices and behavioral science approaches in obesity management.
Interpreting thyroid function tests and understanding referral criteria for children.
Identifying common endocrine emergencies and applying case-based approaches.
Providing comprehensive care in conditions such as achondroplasia.
Moving towards earlier intervention and prevention strategies for Type 1 diabetes.
Reviewing current evidence and emerging strategies in immune modulation.
Exploring islet transplantation and stem cell approaches for Type 1 diabetes.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
